Brean Murray downgrades China Medical (Nasdaq: CMED) from Buy to Hold.

Brean analyst says, "CMED has exceeded our price ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE